L, Z., M, R., X, L., E, S., Jr, B. J., E, S., . . . M, M. (2017). Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis. EBioMedicine, 23, 20. https://doi.org/10.1016/j.ebiom.2017.08.024
Chicago Style (17th ed.) CitationL, Zhenjiang, et al. "Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis." EBioMedicine 23 (2017): 20. https://doi.org/10.1016/j.ebiom.2017.08.024.
MLA (9th ed.) CitationL, Zhenjiang, et al. "Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis." EBioMedicine, vol. 23, 2017, p. 20, https://doi.org/10.1016/j.ebiom.2017.08.024.
Warning: These citations may not always be 100% accurate.